Cargando…

New tumor regression grade for rectal cancer after neoadjuvant therapy and radical surgery

In this retrospective study, we defined a new tumor regression grade (NTRG), which we used to evaluate the prognosis of patients with locally advanced rectal cancer who received neoadjuvant therapy and then underwent radical surgery between June 2004 and October 2011. Calculated as the TRG plus a ly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jun, Liu, Hao, Hu, Junjie, Liu, Sai, Yin, Jie, Du, Feng, Yuan, Jiatian, Lv, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747220/ https://www.ncbi.nlm.nih.gov/pubmed/26540466

Ejemplares similares

Lymph nodes regression grade is a predictive marker for rectal cancer after neoadjuvant therapy and radical surgery
por: Li, Jun, et al.
Publicado: (2016)

Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study
por: Li, Jun, et al.
Publicado: (2015)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

Novel lymph node ratio predicts prognosis of colorectal cancer patients after radical surgery when tumor deposits are counted as positive lymph nodes: a retrospective multicenter study
por: Yang, Jin, et al.
Publicado: (2016)

Development of a method for digital assessment of tumor regression grade in patients with rectal cancer following neoadjuvant therapy
por: Jepsen, Dea Natalie Munch, et al.
Publicado: (2022)

Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
por: He, Lei, et al.
Publicado: (2022)

Tumor Regression Grading of Gastrointestinal Carcinomas after Neoadjuvant Treatment
por: Thies, Svenja, et al.
Publicado: (2013)

Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer
por: Zhang, Shu, et al.
Publicado: (2021)

Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
por: Li, Jia-yi, et al.
Publicado: (2021)

Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
por: Li, Jun, et al.
Publicado: (2016)

Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
por: Li, Shuofeng, et al.
Publicado: (2023)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

Clinical Significance of Tumor Regression Grade in Rectal Cancer with Preoperative Chemoradiotherapy
por: Park, Young Joo, et al.
Publicado: (2010)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

Forecasting Individual Patients’ Best Time for Surgery in Colon-Rectal Cancer by Tumor Regression during and after Neoadjuvant Radiochemotherapy
por: Martorana, Emanuele, et al.
Publicado: (2023)

Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer
por: Rengo, Marco, et al.
Publicado: (2017)

Prognostic Significance of Tumor Regression Grade after Preoperative Chemoradiotherapy for Rectal Cancer
por: Kim, Byung Chun
Publicado: (2011)

Tumor Regression Grades: Can They Influence Rectal Cancer Therapy Decision Tree?
por: Santos, Marisa D., et al.
Publicado: (2013)

Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy
por: Chang, Hui, et al.
Publicado: (2020)

Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
por: Prall, Friedrich, et al.
Publicado: (2015)

Tumor deposits counted as positive lymph nodes in TNM staging for advanced colorectal cancer: a retrospective multicenter study
por: Li, Jun, et al.
Publicado: (2016)

CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy
por: Tong, Yilin, et al.
Publicado: (2021)

ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer
por: Wei, Jiawang, et al.
Publicado: (2018)

Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems
por: Matsuda, Yoko, et al.
Publicado: (2020)

A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy
por: Yu, Yongkui, et al.
Publicado: (2022)

Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy
por: Zhang, Hang, et al.
Publicado: (2020)

Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy
por: Sejben, Anita, et al.
Publicado: (2020)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
por: Zhang, Chi, et al.
Publicado: (2023)

MRI tumour regression grade in locally recurrent rectal cancer
por: Voogt, Eva L.K., et al.
Publicado: (2022)

Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery
por: Chen, Yonghe, et al.
Publicado: (2021)

Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
por: Song, Changhoon, et al.
Publicado: (2018)

Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer
por: Hongo, Kumiko, et al.
Publicado: (2012)

What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
por: Kim, Soo Hee, et al.
Publicado: (2016)

Correlation Between Tumor Regression Grade and Clinicopathological Parameters in Patients With Squamous Cell Carcinoma of the Esophagus Who Received Neoadjuvant Chemoradiotherapy
por: Chao, Yin-Kai, et al.
Publicado: (2015)

Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma
por: Haddad, Riad, et al.
Publicado: (2022)

Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience
por: Yoen, Heera, et al.
Publicado: (2020)

Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients
por: Mei, Shi-Wen, et al.
Publicado: (2020)

Can patients with good tumor regression grading after neoadjuvant chemoradiotherapy be exempted from lateral lymph node dissection?
por: Liu, Xianwei, et al.
Publicado: (2022)

Relevant issues in tumor regression grading of histopathological response to neoadjuvant treatment in adenocarcinomas of the esophagus and gastroesophageal junction
por: Klevebro, F, et al.
Publicado: (2020)

High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer
por: Lin, Ching-Yih, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hvbmv0jm3g3f6g8eskn09q6p57